MannKind Rises After FDA Delays Inhaled Insulin Ruling

944 views · Published 23 March 2012 · 1:12 · Indexed 25 September 2026

Channel: Bloomberg Originals · 2012 · Entertainment

Watch on YouTube

Dec. 28 (Bloomberg) -- MannKind Corp., the biotechnology company founded by the billionaire inventor Alfred Mann, rose the most in four months in Nasdaq trading after U.S. regulators delayed a decision on the company's Afrezza inhaled insulin. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

More from this channel

• 0:17 Pens Tie Stanley Cup Series - Bloomberg

  Bloomberg Originals

  225 views · 5 June 2009

• 0:35 Hardware Price Too High - Activision - Bloomberg

  Bloomberg Originals

  374 views · 5 June 2009

• 0:31 FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg

  Bloomberg Originals

  552 views · 5 June 2009

• 0:44 Bank Have More Accounting Leeway - Bloomberg

  Bloomberg Originals

  513 views · 5 June 2009

• 0:32 Lakers Beat Magic 100-75 - Bloomberg

  Bloomberg Originals

  271 views · 5 June 2009

• 0:30 Johnson Wins 300th Game - Bloomberg

  Bloomberg Originals

  281 views · 5 June 2009

• 1:13 GM Expects To Sell Saturn To Penske Automotive - Bloomberg

  Bloomberg Originals

  467 views · 5 June 2009

• 1:01 Broadway At Tony Awards - Bloomberg

  Bloomberg Originals

  184 views · 5 June 2009